MG
Therapeutic Areas
Cellphire Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CLPH-511 (Cryopreserved Platelets) | Bleeding in thrombocytopenia/platelet dysfunction (e.g., cardiac surgery, trauma) | Phase 2/3 |
| CLPH-211 / CLPH-251 (FPH / Thrombosomes®) | Acute bleeding (trauma, traumatic brain injury) | Phase 2 |